Cargando…
Thioredoxin Is Involved in Endothelial Cell Extracellular Transglutaminase 2 Activation Mediated by Celiac Disease Patient IgA
PURPOSE: To investigate the role of thioredoxin (TRX), a novel regulator of extracellular transglutaminase 2 (TG2), in celiac patients IgA (CD IgA) mediated TG2 enzymatic activation. METHODS: TG2 enzymatic activity was evaluated in endothelial cells (HUVECs) under different experimental conditions b...
Autores principales: | Antonella Nadalutti, Cristina, Korponay-Szabo, Ilma Rita, Kaukinen, Katri, Wang, Zhuo, Griffin, Martin, Mäki, Markku, Lindfors, Katri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793942/ https://www.ncbi.nlm.nih.gov/pubmed/24130874 http://dx.doi.org/10.1371/journal.pone.0077277 |
Ejemplares similares
-
Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits
por: Stenman, Satumarja M, et al.
Publicado: (2008) -
Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
por: Nurmi, Rakel, et al.
Publicado: (2021) -
Automatic classification of IgA endomysial antibody test for celiac disease: a new method deploying machine learning
por: Caetano dos Santos, Florentino Luciano, et al.
Publicado: (2019) -
Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics
por: Kalliokoski, Suvi, et al.
Publicado: (2013) -
Correction: Celiac Disease–Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics
por: Kalliokoski, Suvi, et al.
Publicado: (2014)